News Daily News Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program L.A. McKeown December 21, 2018
News Daily News Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes? Yael L. Maxwell December 10, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Daily News NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field Shelley Wood November 02, 2018
News Opinion Editor's Corner TCT 2018 My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse Shelley Wood October 12, 2018
News Daily News Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans Todd Neale October 09, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Conference News TCT 2018 COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF Shelley Wood September 23, 2018
News Daily News Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66 Todd Neale September 14, 2018
News Conference News ESC 2018 MITRA-FR: No Benefit of MitraClip in Functional MR Shelley Wood August 27, 2018
News Daily News Physician Conflict of Interest Disclosures to Journals for Device-Industry Ties Fall Short Caitlin E. Cox August 24, 2018
News Daily News Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’ Michael O'Riordan August 21, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Features Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere Yael L. Maxwell August 02, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018